Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
11’988 GBX | -0.32% | +9.52% | +13.09% |
15:26 | DZ Bank hebt fairen Wert für Astrazeneca an - 'Halten' | DP |
15:11 | UBS hebt Ziel für Astrazeneca auf 10500 Pence - 'Sell' | DP |
ETFs investiert in AstraZeneca PLC
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
9,20% | 11 M€ | +0.83% | - | |
5,39% | 192 M€ | +13.43% | ||
5,17% | 18 M€ | +3.79% | - | |
4,89% | 776 M€ | +9.34% | ||
4,11% | 88 M€ | +10.37% | - | |
3,47% | 233 M€ | +8.82% | ||
2,74% | 4 M€ | -.--% | - | |
2,57% | 6 M€ | -.--% | ||
2,53% | 5 M€ | +6.34% | - | |
2,53% | 1 331 M€ | +7.08% | ||
1,54% | 29 M€ | +8.37% | - | |
1,51% | 2 M€ | +9.19% | - | |
1,51% | 2 M€ | -.--% | - | |
1,26% | 12 M€ | +15.09% | - | |
1,19% | 49 M€ | +5.28% | ||
1,16% | 10 M€ | -3.35% | - | |
0,97% | 7 M€ | +1.89% | - | |
0,89% | 31 M€ | +3.52% | - | |
0,86% | 276 M€ | +11.40% | - | |
0,70% | 277 M€ | -.--% | - | |
0,69% | 194 M€ | +5.65% | - | |
0,69% | 441 M€ | +10.26% | ||
0,57% | 205 M€ | -.--% | ||
0,54% | 284 M€ | -.--% | ||
0,51% | 23 M€ | -.--% | - | |
0,51% | 786 M€ | -.--% | ||
0,50% | 206 M€ | -.--% | ||
0,48% | 717 M€ | +6.20% | ||
0,43% | 273 M€ | +15.83% |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+13.09% | 233 Mrd. | |
+25.83% | 653 Mrd. | |
+27.00% | 556 Mrd. | |
-6.76% | 354 Mrd. | |
+20.34% | 331 Mrd. | |
+3.00% | 296 Mrd. | |
+5.46% | 201 Mrd. | |
-9.61% | 193 Mrd. | |
-6.26% | 144 Mrd. | |
-11.77% | 143 Mrd. |
- Börse
- Aktien
- 886455 Aktie
- ETFs AstraZeneca PLC